Clinical Trial Update: Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cilengitide and cetuximab with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• cilengitide (cilengitide)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED | Results posted: 2014-09-30